MIAMI, FL -- (MARKET WIRE) -- 02/16/07 -- An estimated 32 million Americans suffer from agonizing migraine headaches, per the National Headache Foundation. According to a recent study, two out of three people with recurring migraines delay or avoid taking prescribed drugs due to concerns about side effects. OTC drugs, such as aspirin and ibuprofen, can cause ulcers and stomach bleeding. Prescription medications may cause pain in the jaw, chest, arm, and head. Fortunately, consumers don't have to choose between the pain of migraines and the dangers of drugs. A new randomized, placebo-controlled human clinical trial found that Migra-Zen Relief Plus®, an herbal supplement manufactured by RZN Nutraceuticals, prevented non sinus related migraine attacks in 100% of people taking it after just 24 days -- without causing any side effects.

The 30-day trial, which evaluated the safety and efficacy of Migra-Zen Relief Plus®, was conducted by independent Fenestra Research Labs. Seventy-five subjects suffering from chronic migraine headaches were randomly divided into three equal groups: placebo, preventive, and therapeutic.

The good news for migraine sufferers is that the product worked beautifully, both preventively and therapeutically. While subjects in the placebo group only had a 2.2 percent reduction in headache frequency, patients taking Migra-Zen therapeutically, 59.3 percent found significant relief in 30 minutes or less and this increased to 93.9 percent after 60 minutes. In the preventive group by day 7, 62.5 percent taking Migra-Zen every day were migraine-free. By day 14, 80%, and by 24th day, not a single person had migraines anymore.

Migra-Zen Relief Plus® is a proprietary blend of extracts of juniper, goldenrod, dandelion, meadowsweet and willow bark, conjugated to fruit sugars and polysaccharides in a patent-pending delivery system that ensures their absorption. How does it stop migraine pain? The lead herb, juniper, is a smooth muscle constrictor. It overrides the message from the nerve cells to dilate the cerebral blood vessels, causing the vasospasms to cease. The other herbs block pain signals and reduce inflammation.

RZN Nutraceutical founder and Chief Scientist Mark Lubin is a biomedical engineer who has 12 U.S. patents issued or pending for biomedical and technical innovations.

For information on Migra-Zen Relief Plus® or the three Arthri-Zen Relief® formulations, www.rznnutra.com or call Robert Hunt at 904-276-8324.

Media contact:
Christie Communications
805-969-3744